🇺🇸 FDA
Patent

US 11452717

Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof

granted A61KA61K31/196A61K31/245

Quick answer

US patent 11452717 (Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/196, A61K31/245, A61K31/415, A61K31/4155